Discovery of SARS-CoV-2 Papain-like Protease Inhibitors through a Combination of High-Throughput Screening and a FlipGFP-Based Reporter AssayChunlong Ma, Jun Wang, Mandy Ba et al.|ACS Central Science|2021Cited by 200
Expedited Approach toward the Rational Design of Noncovalent SARS-CoV-2 Main Protease InhibitorsNaoya Kitamura, Jun Wang, M. Sacco et al.|Journal of Medicinal Chemistry|2021Cited by 168
Rational Design of Hybrid SARS-CoV-2 Main Protease Inhibitors Guided by the Superimposed Cocrystal Structures with the Peptidomimetic Inhibitors GC-376, Telaprevir, and BoceprevirZilei Xia, Jun Wang, M. Sacco et al.|ACS Pharmacology & Translational Science|2021Cited by 102
Discovery of SARS-CoV-2 papain-like protease inhibitors through a combination of high-throughput screening and FlipGFP-based reporter assayZilei Xia, Jun Wang, M. Sacco et al.|bioRxiv (Cold Spring Harbor Laboratory)|2021Cited by 8